Expert consensus on the prevention and control of blood borne pathogen infections related to artificial liver support

doi:10.19871/j.cnki.xfcrbzz.2024.03.020

Abstract

Abstract: Artificial liver support is currently an important means of treating liver failure. As some patients are carriers or infected with blood borne pathogens, both patients and medical staff are at risk of blood borne pathogen infection during the process of extracorporeal circulation. The research on prevention and control strategies for blood borne pathogens related to artificial liver support in China is still in its early stages, lacking standardized and consistent understanding. Hence, this consensus is formed with the effort of nursing experts who were organized by the Infectious Disease Nursing Professional Committee of Chinese Nursing Association organized domestic experts, based on the relevant laws and regulations of national hospital infection prevention and control. Which is also be guided by domestic and foreign literatures related to the current situation of artificial liver support treatment and blood borne pathogen infection prevention and control, and combined with China's clinical diagnosis and treatment guidelines and best clinical practice evidence requirements. Consensus provides clinical guidance for the prevention and control of blood borne pathogen infections related to artificial liver support through risk assessment of various stages of artificial liver support treatment, and the development of safe operation procedures to avoid risks, including the setting of artificial liver rooms, institutional management requirements, prevention and control rules based on patients and medical staff during the treatment process, exposure handling procedures and other 25 expert consensus content. It aims to avoid occupational exposure to blood borne pathogens and hospital acquired infection risks, and ensure the safety of patients and medical staff.

Key words: Artificial liver support, Blood-borne pathogens, Infection prevention and control, Occupational exposure, Expert consensus

CLC Number:

R516

Hu Lingli, Mo Dan, Li Kanghua, Zhang Lihui, Wang Mingming, Luo Mengting, Chen Chong, Zhang Zhiyun, Yuan Su'e. Expert consensus on the prevention and control of blood borne pathogen infections related to artificial liver support[J]. Electronic Journal of Emerging Infectious Diseases, 2024, 9(3): 98-104.

References

[1] SALIBA F, BANARES R, LARSEN FS, et al.Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts[J]. Intensive Care Med, 2022, 48(10):1352-1367.
[2] 中华医学会肝病学分会重型肝病与人工肝学组. 人工肝血液净化技术临床应用专家共识(2022年版)[J].临床肝胆病杂志, 2022, 38(4):767-775.
[3] 乔艳, 刘传苗, 汪小玲, 等.人工肝治疗肝衰竭病人医院感染调查及危险因素分析[J].蚌埠医学院学报, 2023, 48(6):758-761.
[4] 陶玲玲, 程静, 李敏. 维持性血液透析患者丙型肝炎病毒感染危险因素分析[J]. 实用临床医学, 2021, 22(1):86-88+91.
[5] 刘云. 维持性血液透析患者乙型肝炎和丙型肝炎病毒感染情况调查分析[J].河南医学研究, 2017, 26(18):3301-3302.
[6] SAKR CJ, ALAMEDDINE R, HOTEIT R, et al.Occupational Exposure to Blood-Borne Pathogens among Healthcare Workers in a Tertiary Care Center in Lebanon[J]. Ann Work Expo Health, 2021, 65(4):475-484.
[7] FENG H, MAO X, LI M, et al.Analysis of characteristic and postexposure practices of occupational blood and body fluid exposures among health care workers in Chinese tertiary hospitals: a retrospective ten-year study[J]. BMC Infect Dis, 2024, 24(1):256.
[8] 徐世兰. 感控护士医院感染预防与控制手册[M].四川:四川大学出版社,2024.
[9] MÜCKE MM, RUMYANTSEVA T, MÜCKE VT, etal.Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality[J]. Liver Int, 2018, 38(4):645.
[10] 胡世芸, 吴洁姣, 杨雪松, 等. 肝衰竭医院感直接经济损失研究[J].中国感染控制杂志, 2019, 18(9):859.
[11] 国务院办公厅. 国务院办公厅关于推动疾病预防控制事业高质量发展的指导意见[J]. 中国农村卫生, 2024, 16(1):8-10.
[12] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会感染病学分会肝衰竭与人工肝专家委员会, 国家感染性疾病临床医学研究中心,等. 人工肝血液净化系统治疗指南(2023年版)[J].中华临床感染病杂志, 2023, 16(6):401-411.
[13] 国家卫生健康委员会. 血液净化标准操作规程(2021版)[S].国卫办医函[2021]552号, 2021-11-09.
[14] GUVATT GH, OXMAN AD, VIST GE, et al.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ, 2008, 336(7650):924-926.
[15] FAQIHI F, ALHARTHY A, ABDULAZIZ S, et al.Therapeutic plasma exchange in patientswith life-threatening COVID-19:a randomised controlled clinical trial[J].International Journal of Antimicrobial Agents, 2021, 57(5):106334.
[16] 医院隔离技术标准WS/T 311-2023[J].中国感染控制杂志, 2023, 11:1398-1410.
[17] 国家卫生健康委, 国家发展改革委办公厅. 关于印发发热门诊建筑装备技术导则(试行)的通知[Z].国卫办规划函[2020]683号,2020-08-17.
[18] MANDIC B, MANDIC-RAJCEVIC S, MARKOVIC-DENIC L, et al.Occupational exposure to blood and b-odily fluids among healthcare workers in Serbian general hospitals[J]. Arh Hig Rada Toksikol, 2018, 69(1):61-68.
[19] 彭莉利, 刘春来, 张卫平, 等. 2019-2020年某市30所医院医护人员血源性职业暴露调查[J]. 中华医院感染学杂志, 2022, 32(8):1239-1242.
[20] VALDENEBRO M, MARTIN-RODRIGUEZ L, TARRAGON B, et al.Renal replacement therapy in critirally ill patients with acute kidney injury: 2020 nephrologist's perspertive[J]. Nefrologia (Engl Ed), 2021, 41(2):102-114.
[21] PARK HC, LEE YK, YOO KD, et al.Korean clinical practice guidelines for preventingthetransmission of infections in hemodialysis facilities[J].Kidney Res Clin Pract, 2018, 37(1):8-19.
[22] 方映雪, 王忠芳. 终末期肾病患者医院感染危险因素及干预研究进展[J]. 中国消毒学杂志, 2021, 38(1):63-66.
[23] 国家卫生计生委. 国家卫生计生委关于印发血液透析中心基本标准和管理规范(试行)的通知[J].中华人民共和国国家卫生和计划生育委员会公报, 2016, (12):16-23.
[24] 谢泉琨, 刘书真, 陈慧娜, 等.维持性血液透析患者感染乙型肝炎和丙型肝炎病毒的危险因素分析[J].中华医院感染学杂志, 2017, 27(8):1721-1724.
[25] 皮伟珍, 莫丹, 李好, 等. 经皮股静脉人工肝临时血管通路管理的专家共识[J]. 循证护理, 2022, 8(5):614-619.
[26] REWARI V, RAMACHANDRAN R, PANDE A.Compression with the ultrasound probe to prevent malposition of central venous catheter in the ipsilateral internal jugular vein during axillary vein cannulation[J]. J Clin Ultrasound, 2019, 47(2):95-96.
[27] OLETI T, JEEVA SANKAR M, THUKRAL A, et al.Does ultrasound guidance for peripherally inserted central catheter (PICC) insertion reduce the incidence of tip malposition a randomized trial[J].J Perinatol,2019,39(1):95-101.
[28] 中华护理学会静脉输液治疗专业委员会. 静脉导管常见并发症临床护理实践指南[J]. 中华现代护理杂志, 2022, 28(18): 2381-2395.
[29] 梁静, 尹运冬, 孙一楠, 等. 某三级儿童医院10年医务人员血源性职业暴露资料分析[J].中国感染控制杂志, 2023, 21(11): 1291-1297.
[30] 陈建伟, 潘磊, 姜雪锦, 等.2018-2021年山东省某综合医院血源性职业暴露状况[J].中华医院感染学杂志, 2023, 33(14):2190-2194.
[31] 袁月, 李可萍, 庄英杰, 等. 传染病专科医院血源性病原体职业接触监测分析与对策[J].传染病信息, 2021, 34(2):169-171.
[32] SILVA DMD, MARQUES BM, GALHARDI NM, et al.Hands hygiene and the use of gloves by nursing team in hemodialysis service[J].Rev Bras Enferm, 2018, 71(4):1963-1969.
[33] JARDINE M, COMMONS RJ, DE ZOYSA JR, et al.Kidney Health Australia-Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units[J]. Nephrology (Carlton), 2019, 24(9):951-957.
[34] 邱自辉, 李其彪, 陈宇, 等. 血浆置换联合胆红素吸附治疗肝衰竭的临床研究[J/CD].新发传染病电子杂志, 2016, 1(1):45-47.
[35] 医疗机构环境表面清洁与消毒管理规范WS/T512—2016[J].中国感染控制杂志, 2017, 16(4): 388-392.
[36] 申文亚. 某三甲医院医务人员血源性病原体职业接触及防控措施落实情况研究[D].北京协和医学院, 2023.
[37] 刘英, 肖明朝, 罗松, 等. 2015—2018年某三级综合医院医护人员血源性职业暴露情况调查及安全防控体系构建[J].中国公共卫生,2021, 37(1):149-152.
[38] 袁素娥, 陈煜, 蔡小芳, 等. 安全采集成人静脉血标本共识[J].中国感染控制杂志, 2021, 20(9): 775-781.